Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.39 |
| ▸ | M6PR | P20645 | 2/20 | 0.35 |
| ▸ | FGF1 | P05230 | 3/20 | 0.35 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.34 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.34 |
| ▸ | CCL2 | P13500 | 1/20 | 0.34 |
| ▸ | CCL5 | P13501 | 1/20 | 0.34 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.34 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.33 |
| ▸ | BDNF | P23560 | 3/20 | 0.32 |
| ▸ | PTN | P21246 | 2/20 | 0.32 |
| ▸ | MDK | P21741 | 2/20 | 0.32 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19441368 | 1.00 | F10 (0.39) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL14586220 | 1.00 | F10 (0.39) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL12878540 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL22139521 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL17739731 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL12458629 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL20370858 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL12384884 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL12755226 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 | |
| SCHEMBL20363547 | 0.89 | F10 (0.43) | F10M6PRFGF1CXCL10CXCL8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137503-A1 | HIGHLY POROUS AEROGELS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-05-19 | — | — | US | disclosed |
| US-8389661-B2 | Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs | ADOCIA (FR) | 2013-03-05 | — | — | US | disclosed |
| US-8192987-B2 | Human dental follicle stem cells and methods for obtaining | TISSUEDENT GMBH & CO. KG (DE) | 2012-06-05 | — | — | US | disclosed |
| US-20100062232-A1 | MULTILAYER FILMS | DREXEL UNIVERSITY (US) | 2010-03-11 | — | — | US | disclosed |
| US-20090221805-A1 | Complex polymere amphiphile-PDGF | PROTEINS AND PEPTIDES MANAGEMENT (FR) | 2009-09-03 | — | — | US | disclosed |
| US-20090048412-A1 | Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs | ADOCIA (FR) | 2009-02-19 | — | — | US | disclosed |
| US-20090035282-A1 | Pluripotent embryonic-like stem cells derived from teeth and uses thereof | STIFTUNG CAESAR | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035282-A1 | Pluripotent embryonic-like stem cells derived from teeth and uses thereof | ALPG, WAPL, SALL4 | F10 4417/4885M6PR 2531/4885FGF1 241/4885 |
| US-20090221805-A1 | Complex polymere amphiphile-PDGF | PDGFA, PDGFRA, FIBP | F10 1363/4885M6PR 1532/4885FGF1 98/4885 |
| US-20090048412-A1 | Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPs | BMP2, BMP1, BMP6 | F10 246/4885M6PR 254/4885FGF1 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.